Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

WDNA vs CANC overlap: 22% of top holdings shared

Bottom line

How much do WDNA and CANC overlap?

22% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 14.4% of WDNA's assets and 24.6% of CANC's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

WDNACANC
Weight overlap (top 25)22%
Shared holdings6
Weight in shared holdings14.4%24.6%
Total positions8157
Expense ratio0.45%0.75%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings WDNA and CANC have in common

Holding% of WDNA% of CANCOverlap
Eli Lilly & Company LLY4.08%4.82%4.08%
Johnson & Johnson JNJ2.97%2.55%2.55%
Immunome Inc IMNM2.26%3.91%2.26%
Astrazeneca Plc AZN1.83%3.54%1.83%
Revolution Medicines Inc RVMD1.69%7.73%1.69%
Amgen Inc AMGN1.54%2.11%1.54%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in WDNA

  1. Twist Bioscience Corp — 5.95%
  2. Moderna Inc — 4.14%
  3. United Therapeutics Corp — 2.45%
  4. Natera Inc — 2.32%
  5. Tempus Ai Inc — 2.28%
  6. Structure Therapeutics Inc — 2.11%
  7. Stoke Therapeutics Inc — 2.09%
  8. Beam Therapeutics Inc — 2.09%
  9. Corteva Inc — 1.99%
  10. Krystal Biotech Inc — 1.96%
  11. Darling Ingredients Inc — 1.94%
  12. Ionis Pharmaceuticals Inc — 1.86%
  13. 10x Genomics Inc — 1.81%
  14. Crispr Therapeutics Ag — 1.77%
  15. Roivant Sciences Ltd — 1.73%

Only in CANC

  1. Roche Holding AG — 4.21%
  2. Cogent Biosciences Inc — 4.10%
  3. Novartis AG — 4.03%
  4. Celcuity Inc — 3.58%
  5. Merck & Co Inc — 3.57%
  6. Nuvalent Inc — 3.37%
  7. Bristol-Myers Squibb Co — 3.30%
  8. Legend Biotech Corp — 2.99%
  9. AbbVie Inc — 2.81%
  10. Exelixis Inc — 2.78%
  11. Bridgebio Pharma Inc — 2.75%
  12. CG oncology Inc — 2.43%
  13. Genmab A/S — 2.37%
  14. Ideaya Biosciences Inc — 2.27%
  15. Zai Lab Ltd — 1.98%

Asset mix

Asset typeWDNACANC
Stocks99.9%99.0%
Cash & short-term funds0.1%1.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryWDNACANC
US79.2%80.9%
CH4.6%8.2%
GB2.6%4.0%
DE3.1%1.1%
NL2.4%—
DK1.8%2.4%
KY2.1%0.3%
CN—2.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do WDNA and CANC overlap?
About 22% by weight. 6 securities appear in both funds' top 25 holdings; they make up 14.4% of WDNA's assets and 24.6% of CANC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do WDNA and CANC have in common?
The largest shared holdings are Eli Lilly & Company, Johnson & Johnson, Immunome Inc, Astrazeneca Plc, Revolution Medicines Inc.
Should I own both WDNA and CANC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, WDNA or CANC?
WDNA is broader, with 81 positions versus 57 for CANC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.